A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Gilead Sciences inc.: I began accumulating shares on November 19th, 2010. The stock is up 8.6% and continues toigrow, making at a great value stock. It's Beta is low which eliminates a lot of stress for those of you who prefer a stock that provides steady growth, rather than huge swings in the stocks price. Gilead is a 4 star stock in my book.